ask="12.30"
ask_size="1000"
average_daily_volume="27141"
bid="N/A"
bid_size="N/A"
book_value="3.34"
change="-0.27"
change_from_200_day_moving_average="3.90"
change_from_50_day_moving_average="2.19"
change_from_52_week_high="-0.37"
change_From_52_week_low="7.11"
change_in_percent="-2.48%"
close="10.63"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.26"
ebitda="-50.28M"
eps_estimate_current_year="-2.54"
eps_estimate_next_quarter="-0.60"
eps_estimate_next_year="-2.57"
ex_dividend_date="N/A"
float_shares="N/A"
high="10.80"
high_52_weeks="11.00"
last_trade_date="2/23/2017"
last_trade_price="10.63"
last_trade_size="200"
last_trade_time="3:59pm"
low="10.63"
low_52_weeks="3.52"
market_capitalization="226.21M"
moving_average_200_day="6.73"
moving_average_50_day="8.44"
name="Nabriva Therapeutics AG"
notes="N/A"
one_year_target_price="15.83"
open="10.70"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+58.03%"
percent_change_from_50_day_moving_average="+26.00%"
percent_change_from_52_week_high="-3.36%"
percent_change_from_52_week_low="+201.99%"
previous_close="10.90"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.26"
price_per_sales="44.61"
revenue="5.20M"
shares_outstanding="21280000"
short_ratio="3.79"
stock_exchange="NMS"
symbol="NBRV"
volume="6351"
weeks_range_52="3.52 - 11.00"
